HOOKIPA Pharma Statistics
Share Statistics
HOOKIPA Pharma has 12.18M
shares outstanding. The number of shares has increased by -87.51%
in one year.
| Shares Outstanding | 12.18M |
| Shares Change (YoY) | -87.51% |
| Shares Change (QoQ) | 24.9% |
| Owned by Institutions (%) | 42.51% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 103 |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 29.87K, so 0.25% of the outstanding
shares have been sold short.
| Short Interest | 29.87K |
| Short % of Shares Out | 0.25% |
| Short % of Float | 0.39% |
| Short Ratio (days to cover) | 1.15 |
Valuation Ratios
The PE ratio is -0.58 and the forward
PE ratio is -0.82.
HOOKIPA Pharma's PEG ratio is
0.01.
| PE Ratio | -0.58 |
| Forward PE | -0.82 |
| PS Ratio | 0.57 |
| Forward PS | 0.8 |
| PB Ratio | 0.49 |
| P/FCF Ratio | -0.33 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for HOOKIPA Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27,
with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.27 |
| Quick Ratio | 3.27 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.01 |
| Interest Coverage | -25727.5 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $535,926.83 |
| Profits Per Employee | $-530,524.39 |
| Employee Count | 82 |
| Asset Turnover | 0.53 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -106K |
| Effective Tax Rate | 0.24% |
Stock Price Statistics
The stock price has increased by -82.11% in the
last 52 weeks. The beta is 0.75, so HOOKIPA Pharma's
price volatility has been higher than the market average.
| Beta | 0.75 |
| 52-Week Price Change | -82.11% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 2.81 |
| Relative Strength Index (RSI) | 59.51 |
| Average Volume (20 Days) | 81,308 |
Income Statement
In the last 12 months, HOOKIPA Pharma had revenue of 43.95M
and earned -43.5M
in profits. Earnings per share was -3.47.
| Revenue | 43.95M |
| Gross Profit | 43.95M |
| Operating Income | -51.45M |
| Net Income | -43.5M |
| EBITDA | -40.85M |
| EBIT | -43.61M |
| Earnings Per Share (EPS) | -3.47 |
Full Income StatementBalance Sheet
The company has 39.68M in cash and 875K in
debt, giving a net cash position of 38.81M.
| Cash & Cash Equivalents | 39.68M |
| Total Debt | 875K |
| Net Cash | 38.81M |
| Retained Earnings | -412.76M |
| Total Assets | 82.55M |
| Working Capital | 56.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -76.98M
and capital expenditures 0, giving a free cash flow of -77.17M.
| Operating Cash Flow | -76.98M |
| Capital Expenditures | n/a |
| Free Cash Flow | -77.17M |
| FCF Per Share | -6.15 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -117.09% and -98.99%.
| Gross Margin | 100% |
| Operating Margin | -117.09% |
| Pretax Margin | -99.23% |
| Profit Margin | -98.99% |
| EBITDA Margin | -92.96% |
| EBIT Margin | -117.09% |
| FCF Margin | -175.61% |
